Exuviance Daily Acne Peel Exfoliating Anti-blemish Pads
NDC Package 58414-2021-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Exuviance Daily Acne Peel Exfoliating Anti-blemish Pads is a . Marketed by Neostrata Company Inc., this product is identified by NDC 58414-2021 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
58414-2021-1
Package Description
1 JAR in 1 CARTON / 36 APPLICATOR in 1 JAR / 1.11 mL in 1 APPLICATOR
Product Code
58414-2021
11-Digit Billing Format
58414202101

Clinical Specifications

Proprietary Name
Exuviance Daily Acne Peel Exfoliating Anti-blemish Pads
Dosage Form
-

Regulatory & Marketing

Labeler Name
Neostrata Company Inc.
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-01-2015
End Marketing Date
06-16-2018
Listing Expiration
06-16-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58414-2021-1 identifies a specific commercial package of 1 jar in 1 carton / 36 applicator in 1 jar / 1.11 ml in 1 applicator of Exuviance Daily Acne Peel Exfoliating Anti-blemish Pads, labeled by Neostrata Company Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neostrata Company Inc. on March 01, 2015. The current certification is valid through June 16, 2018.

How is this Neostrata Company Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58414202101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
58414-2021-1
11-Digit CMS (5-4-2)
58414-2021-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.